Proof-of-concept study holds promise for safer gene therapy techniques for treating immunodeficiencies Post author: Post published:November 1, 2023 Post category:uncategorized Researchers described an approach to edit the recombination-activating gene 2 (RAG2) locus for therapeutic applications. You Might Also Like Calcium channel blockers: A new hope for pregnant women with vasospastic angina December 6, 2023 Innovative brain simulation enhances understanding of neuron formation October 18, 2024 The Pouch That Improves Type 1 Diabetes Islet Cell Transplants December 15, 2023